Inventor · disambiguated record
Xing Wang
Also filed as: WANG XING · WANG XING FA
3 granted patents·16 pending applications·6 citations·filing 2004–2025
59Inventor score
Files withHUIGENE THERAPEUTICS CO LTD5HUIDAGENE THERAPEUTICS SINGAPORE PTE LTD3ARRAY BRIDGE INC2RENSSELAER POLYTECH INST2ATOM BIOWORKS INC1
Top patents by PatentIndex Score
19 records- 0170US8435962B2Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fatZHU HAIBO·Filed 2009·Granted May 7, 2013·3 cites·10 claims
- 0265US10180434B2Antibody array used for the analysis of the three-dimensional structure of protein therapeutics and its productionARRAY BRIDGE INC·Filed 2013·Granted Jan 15, 2019·1 cites·17 claims
- 0359US2025207115A1Engineered crispr-cas13f system and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2023·Application pending·0 cites
- 0458US2023058054A1Crispr/cas system and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0558US2025205366A1Guide nucleic acid targeting mecp2 and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2023·Application pending·0 cites
- 0657US2022389398A1Engineered crispr/cas13 system and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0757US2025270529A1Engineered crispr-cas13f system and uses thereofHUIDAGENE THERAPEUTICS SINGAPORE PTE LTD·Filed 2022·Application pending·0 cites
- 0851US2023417749A1Polynucleotide nanostructures for detecting viral infections and other diseasesATOM BIOWORKS INC·Filed 2021·Application pending·0 cites
- 0951US2023212643A1Dna nanoarchitectures for pattern-recognized targeting of diseasesRENSSELAER POLYTECH INST·Filed 2020·Application pending·0 cites
- 1050US2025375443A1Identification and use of shp2 conformational disruptors for cancer treatmentWANG XING·Filed 2025·Application pending·0 cites
- 1147US2024209396A1Small cas proteins and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 1246US2023086489A1Novel design of guide rna and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1344US2014051104A1Methods for protein purification and analysisARRAY BRIDGE INC·Filed 2013·Application pending·0 cites
- 1444US2023075045A1Engineered crispr/cas13 system and uses thereofHUIGENE THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1543US7415360B2Multiparameter method of screening for atherosclerosis-related coronary heart disease or strokeWANG XING FA·Filed 2004·Granted Aug 19, 2008·2 cites·10 claims
- 1639US2020405649A1Dna origami nanoparticle delivery of programmed chromosome breakage machineryRENSSELAER POLYTECH INST·Filed 2018·Application pending·0 cites
- 1737US2013029377A1Recombinant apoa-1m from engineered bacteriaPFIZER·Filed 2012·Application pending·0 cites
- 1835US2019121334A1Advisory system for industrial plantsBAKER HUGHES A GE CO LLC·Filed 2018·Application pending·0 cites
- 1932US2022233715A1Aav mutant that efficiently infects supporting cellsCENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECH CHINESE ACADEMY OF SCIENCES·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xing Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →